Huxley SANSA Home Sleep Apnea Test (1000-00)

by Huxley Medical  · Based in United States → — Clarity from Breath to Beat.
Cardiology Pulmonology Sleep Medicine

Regulatory Status Disclosed

Overview

The Huxley SANSA Home Sleep Apnea Test (1000-00) is an innovative, FDA-cleared wearable patch designed to simplify and enhance the diagnosis of sleep-related breathing disorders, particularly Obstructive Sleep Apnea (OSA), and comorbid cardiac arrhythmias. This single-point-of-skin-contact device eliminates the need for cumbersome wires, belts, or hoses, offering an app-free workflow with built-in cellular data upload for seamless transmission of results to healthcare providers.

SANSA utilizes advanced signal processing and AI-powered auto-scoring algorithms to analyze nine physiological data channels, including blood oxygen saturation (SpO2), ECG-derived heart rate, respiratory effort, chest movement, sleep staging (sleep/wake), snoring, body position, and actigraphy. It provides comprehensive insights into sleep health and cardiac rhythms, enabling physicians to make more informed diagnoses and treatment plans.

Validated in multi-site clinical trials, SANSA has demonstrated high accuracy, sensitivity, and specificity comparable to in-laboratory polysomnography (PSG) for detecting mild, moderate, and severe OSA. The device is intended for clinical and home use under the direction of a Healthcare Professional (HCP) and is available by prescription only.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Wearable chest patch design
  • App-free workflow
  • Built-in cellular data upload
  • AI-powered auto-scoring algorithms
  • 9 physiological data channels (ECG, SpO2, Heart Rate, Respiratory Effort, Chest Movement, Body Position, Actigraphy, Snoring, Sleep/Wake Staging)
  • Multi-day monitoring capability
  • Comfortable and non-invasive
  • Validated against polysomnography (PSG)
  • Streamlined diagnostic process for HCPs
  • Secure end-to-end encryption

Use Cases

  • Diagnosis of Obstructive Sleep Apnea (OSA)
  • Detection of cardiac arrhythmias (e.g., atrial fibrillation) during sleep
  • Remote patient monitoring for sleep and cardiac health
  • Streamlining diagnostic workflows for sleep and cardiology practices
  • Reducing patient referral processes and clinic visits
  • Improving access to sleep apnea diagnosis

What Physicians Need to Know

ECG/EKG Analysis Capability
The SANSA device includes a single-lead ECG sensor and provides an ECG reference channel to record electrical signals from the heart. It is FDA-cleared to be used as a diagnostic ECG monitor, offering insight into cardiac arrhythmias like atrial fibrillation.
Arrhythmia Detection Accuracy
The SANSA device is capable of offering diagnostic insight into cardiac arrhythmias, such as atrial fibrillation. In a series of cardiology patients suspected of sleep apnea wearing SANSA, 30% had meaningful arrhythmias on ECG. A case study highlighted its potential to detect previously unrecognized cardiac arrhythmias simultaneously with sleep apnea.
Heart Failure Risk Prediction
SANSA can explore cardiovascular risk through hypoxic burden and ECG. The device also measures hemodynamic parameters associated with heart failure progression. Sleep-disordered breathing, including obstructive and central sleep apnea, is highly prevalent in heart failure and contributes to adverse outcomes. SANSA's ability to differentiate central sleep apnea is particularly relevant for patients with cardiovascular comorbidities like heart failure and atrial fibrillation.
Cardiac Monitoring Integration
SANSA is the only home sleep apnea test that enables simultaneous evaluation of sleep apnea, ECG, and hypoxic burden from a single chest-worn patch. It integrates nine physiological channels, including a single-lead ECG sensor, into a single chest-worn patch. The data uploads automatically over integrated cellular, eliminating the need for smartphone apps or Bluetooth pairing.
AHA/ACC Guideline Alignment
The SANSA device is designed to be a complementary tool for cardiologists to enable guideline-directed care at scale, particularly as electrophysiologists and cardiologists focus on addressing modifiable risk factors like sleep apnea to optimize outcomes.
Real-Time Alert Capability
The cellular-enabled feature allows near real-time data transmission to physicians, streamlining workflows and accelerating time to diagnosis for sleep apnea patients.
Physician Tip

The Huxley SANSA Home Sleep Apnea Test provides a unique opportunity to simultaneously assess sleep apnea and gain insights into cardiovascular risk through its integrated ECG and hypoxic burden measurements. This can be particularly valuable for patients with cardiovascular comorbidities such as atrial fibrillation and heart failure, where sleep apnea is highly prevalent and can worsen outcomes. The ability to differentiate between obstructive and central sleep apnea is crucial for guiding appropriate treatment decisions. The device's ease of use and cellular data upload simplify the diagnostic workflow, potentially improving patient compliance and expediting care. While the ECG provides diagnostic insight into arrhythmias, it's important to remember that the ECG channel is for diagnostic purposes and not intended for automated ECG analysis systems or algorithms. The SANSA system is prescription-use only and intended for use under the direction of a Healthcare Professional.

The Huxley SANSA Home Sleep Apnea Test utilizes a cloud-native platform, Huxley HUB™, which offers seamless EHR integration for ordering and reporting directly through your electronic health record system. Data uploads automatically over integrated cellular, eliminating the need for smartphone apps or Bluetooth pairing, which simplifies the process for patients. The platform provides secure, HIPAA compliant data accessible anytime from any browser.

Details

Category Cardiology AI, Wearables & Remote Monitoring (RPM)
Pricing Unknown
DeploymentCloud-native platform, accessible from any browser.
Mobile AppNo, data uploads automatically over integrated cellular, eliminating the need for a smartphone app or Bluetooth.
Compliance
BAA AvailableUnknown
HIPAA Compliant Yes AI-estimated
FDA Status Yes AI-estimated
Integrations
EHR Not specified
Specialties Cardiology, Pulmonology, Sleep Medicine

Support & Reliability

What the Web Says

The Huxley SANSA Home Sleep Apnea Test (1000-00) is an FDA-cleared, chest-worn patch designed for at-home diagnosis of obstructive sleep apnea (OSA) and central sleep apnea (CSA), as well as ECG monitoring. Clinical studies have shown its performance to be comparable to in-laboratory polysomnography (PSG), the gold standard for sleep apnea diagnosis, with high sensitivity and specificity for detecting moderate-to-severe OSA and excellent accuracy for CSA. Physicians and medical experts have lauded its ease of use, multi-diagnostic capabilities, and reliable performance across diverse patient populations and skin tones.

Overall: Positive

Strengths

  • FDA-cleared for obstructive and central sleep apnea detection, and ECG.
  • Comparable accuracy to in-laboratory polysomnography (PSG).
  • Single-point-of-contact patch design simplifies application and patient training.
  • Assesses obstructive sleep apnea, central sleep apnea, and ECG from a single patch, offering multi-diagnostic potential.
  • Demonstrates reliable performance across all skin tones.
  • Improved patient compliance and comfort due to its non-invasive nature.

Limitations

  • Some Reddit users express concerns about the disposability of similar home sleep apnea tests, citing potential wastefulness.
  • General concerns on Reddit about home sleep apnea tests having false negatives or being less accurate than in-lab studies.
  • Some home sleep apnea tests may not be covered by insurance, or require an in-lab study if initial results are inconclusive.

Based on reviews from: Sleep apnea test | SANSA by Huxley, Validation Study of SANSA Home Sleep Apnea Test Published in Frontiers in Neurology, Huxley Medical Announces | Patient Care Online, FDA Clears Central Sleep Apnea Detection in Huxley Medical Home Test, Peer-Reviewed Study Validates Accuracy of SANSA Home Sleep Apnea Test, SANSA Sleep Apnea Diagnostic Patch Cleared By FDA - SleepWorld Magazine, A single use, at home, disposable, sleep apnea study wearable device. - Reddit, Polysomnography validation of SANSA to detect obstructive sleep apnea - PMC - NIH, FDA Clears Wearable Patch to Aid in Sleep Apnea Detection at Home, Polysomnography validation of SANSA to detect obstructive sleep apnea - PubMed, U.S. Food and Drug Administration Gives Huxley Medical 510(k) Clearance for SANSA Home Sleep Apnea Test - ATDC, FDA Clears SANSA Chest-Worn Sleep Apnea Diagnostic Patch | Respiratory Therapy, Is there a downside to an at home apnea test? : r/SleepApnea - Reddit, The at-home sleep study didn't diagnose me (22m) with sleep apnea, and the doctor wants to charge me $750 to do the official sleep study. She heavily suggested it won't show anything. What do I do? : r/SleepApnea - Reddit, I got my at home sleep study results. It was "normal". I am devastated. - Reddit, Disposable Home Sleep Study : r/SleepApnea - Reddit, Best Home Sleep Apnea Test in 2025: A Complete Buyer's Guide - iSLEEP

Last updated: 2026-10-25

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Huxley SANSA Home Sleep Apnea Test (1000-00)

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

PR Newswire (via Huxley Medical)
Huxley Medical Expands SANSA Diagnostic Platform with Point-of-Care Enrollment and Additional Cardiovascular Risk Marker
Huxley Medical introduced SANSA GO, a point-of-care enrollment model, and hypoxic burden, a new cardiovascular risk marker, to its SANSA platform, building on existing FDA clearances for multi-diagnostic monitoring.
2026-10
FDA
Huxley SANSA Home Sleep Apnea Test (1000-00) FDA 510(k) Clearance
The Huxley SANSA Home Sleep Apnea Test (1000-00) received 510(k) clearance from the FDA on July 15, 2024, classified as a Ventilatory Effort Recorder.
2024-07
Physician AI Tools
Huxley Medical: Products, FDA Status & Funding | Physician AI Tools
Huxley SANSA is an FDA-cleared, AI-powered wearable patch for home sleep apnea and cardiac arrhythmia diagnosis, offering an app-free, cellular-enabled solution for streamlined patient care.
2026-10
PMC (via MDPI)
Machine Learning-Enabled Medical Devices Authorized by the US Food and Drug Administration in 2024: Regulatory Characteristics, Predicate Lineage, and Transparency Reporting
The Huxley SANSA Home Sleep Apnea Test (1000-00) (K240285) was among the 168 ML-enabled medical devices authorized by the FDA in 2024, cleared via the 510(k) regulatory pathway for obstructive sleep apnea diagnosis.
2025-12
Huxley Medical (via PR Newswire)
Huxley Medical Announces FDA Clearance for Central Sleep Apnea Detection and Appointment of Dr. Nancy A. Collop as Medical Director of Sleep Medicine
Huxley Medical announced FDA 510(k) clearance and commercial release of central sleep apnea detection for its SANSA home sleep apnea test, and the appointment of Nancy A. Collop, MD, as Medical Director of Sleep Medicine.
2026-10
OUCI (Book Chapter)
Emerging biosensor technologies for obstructive sleep apnea: A comprehensive overview and future prospects
The Huxley SANSA Home Sleep Apnea Test (1000-00) 510(k) premarket notification is referenced in a book chapter discussing emerging biosensor technologies for obstructive sleep apnea.
2025

Videos

Product demos, reviews, and walkthroughs for Huxley SANSA Home Sleep Apnea Test (1000-00).

No videos found. Search YouTube directly

View all on YouTube

Frequently Asked Questions

The Huxley SANSA device provides raw sleep data that can be exported and potentially integrated with cardiology AI platforms through APIs or data transfer protocols. This allows for the incorporation of sleep apnea diagnosis into a comprehensive cardiovascular risk assessment, aiding in personalized treatment plans and monitoring of patients with co-morbidities.
The Huxley SANSA utilizes proprietary algorithms to analyze respiratory effort, airflow, oxygen saturation, and heart rate data to identify sleep apnea events. While the general validation of these algorithms is available, specific validation studies focusing on diverse cardiac patient populations with varying degrees of cardiovascular disease are crucial for understanding its accuracy and reliability in this high-risk group.
Patient compliance with home sleep apnea tests can vary, but the Huxley SANSA aims for ease of use with its wearable design. Features like simplified setup, clear instructions, and potentially app-based reminders or progress tracking can help improve adherence. For cardiac patients with limitations, additional support from clinical staff during setup and follow-up may be necessary to ensure successful testing.
Alternatives to the Huxley SANSA include in-laboratory polysomnography (PSG) and other home sleep apnea tests (HSATs). PSG remains the gold standard for comprehensive sleep evaluation, especially in complex cases or when other sleep disorders are suspected. Physicians might choose PSG for cardiac patients with atypical symptoms, significant comorbidities, or when a higher level of diagnostic detail is required. Other HSATs may offer different form factors or data parameters, influencing choice based on patient preference or specific clinical needs.
The pricing structure for the Huxley SANSA typically involves the cost of the device itself, and there may be associated fees for data analysis, cloud platform access, or report generation. Specific reimbursement codes (CPT codes) for home sleep apnea testing are available and generally cover the diagnostic service. Cardiology practices should verify current pricing and reimbursement details with the manufacturer and their billing department to understand the financial implications.
While effective for obstructive sleep apnea, the Huxley SANSA, like many HSATs, may have limitations in accurately differentiating between obstructive and central sleep apnea, or in detecting complex sleep disorders like Cheyne-Stokes respiration, which are highly relevant in cardiac patients, particularly those with heart failure. In such cases, a full in-laboratory polysomnography (PSG) may be necessary to obtain a more comprehensive and accurate diagnosis, guiding appropriate management strategies.
The Huxley SANSA adheres to stringent data security and patient privacy protocols, including compliance with regulations like HIPAA in the United States and GDPR in Europe. Data encryption, secure cloud storage, and access controls are typically implemented to protect sensitive patient information. When integrating with EHRs or other systems, secure APIs and data transfer methods are utilized to maintain data integrity and confidentiality.

Related Tools

EchoMD AutoEF
Caption Health (formerly Bay Labs, now part of GE HealthCare)
Cardiology AI
EchoMD AutoEF is an FDA-cleared AI software that automates the selection of echocardiogram clips and calculates left ventricular ejection fraction (EF), enhancing efficiency and accuracy in cardiac assessments.
ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm
Anumana, Inc.
Cardiology AI
An AI algorithm for screening cardiac amyloidosis using standard 12-lead ECGs.
DEEPVESSEL Plaque
Keya Medical Technology Co., Ltd.
Cardiology AI
An AI software platform for coronary plaque analysis and quantification from CT angiography.
WatchMate Software
Anumana, Inc.
Cardiology AI
Anumana is an AI-driven health technology company from nference, developing and delivering ECG algorithms enabling early diagnosis and intervention.
syngo.CT Coronary Cockpit
Siemens Healthineers
Cardiology AI
syngo.CT Coronary Cockpit is an AI-powered software tool by Siemens Healthineers for efficient and accurate CT coronary angiography analysis.
HeartLung AI-CVD®
HeartLung Corporation
Cardiology AI
HeartLung AI-CVD® is an FDA-cleared AI-powered quantitative imaging tool that provides automated CT-derived measurements for assessing cardiovascular and multisystem risks opportunistically.

See all Cardiology AI tools →

More from Huxley Medical

SANSA HSAT
Huxley Medical
Neurology AI
Huxley Medical's SANSA HSAT is an FDA-cleared, AI-powered, app-free chest-worn diagnostic patch for home sleep apnea testing, providing streamlined diagnosis of Obstructive and Central Sleep Apnea by analyzing 9 physiological data channels.

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-04-18 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.